West Pharmaceutical Services Company Profile (NYSE:WST)

About West Pharmaceutical Services

West Pharmaceutical Services logoWest Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company's segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NYSE
  • Symbol: WST
  • CUSIP: 95530610
Key Metrics:
  • Previous Close: $73.51
  • 50 Day Moving Average: $80.66
  • 200 Day Moving Average: $75.12
  • 52-Week Range: $52.79 - $84.33
  • Trailing P/E Ratio: 53.54
  • Foreward P/E Ratio: 28.06
  • P/E Growth: 1.77
  • Market Cap: $5.38B
  • Outstanding Shares: 73,217,000
  • Beta: 0.87
  • Net Margins: 6.99%
  • Return on Equity: 14.40%
  • Return on Assets: 8.98%
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 2.75%
  • Quick Ratio: 1.93%
Additional Links:
Companies Related to West Pharmaceutical Services:

Analyst Ratings

Consensus Ratings for West Pharmaceutical Services (NYSE:WST) (?)
Ratings Breakdown: 3 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $74.78 (1.72% upside)

Analysts' Ratings History for West Pharmaceutical Services (NYSE:WST)
DateFirmActionRatingPrice TargetDetails
9/26/2016Janney Montgomery ScottReiterated RatingBuy -> Fair Value$90.00 -> $72.55View Rating Details
9/21/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
8/4/2016Jefferies GroupReiterated RatingHoldView Rating Details
(Data available from 9/28/2014 forward)


Earnings History for West Pharmaceutical Services (NYSE:WST)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216$0.56$0.59$384.58 million$388.00 millionViewListenView Earnings Details
4/28/2016Q116$0.51$0.53$355.86 million$362.10 millionViewListenView Earnings Details
2/18/2016Q415$0.47$0.47$364.76 million$359.70 millionViewListenView Earnings Details
10/29/2015Q315$0.43$0.44$355.90 million$344.50 millionViewListenView Earnings Details
7/30/2015Q215$0.45$0.47$356.33 million$359.70 millionViewListenView Earnings Details
4/30/2015Q115$0.40$0.45$346.64 million$335.90 millionViewListenView Earnings Details
2/19/2015Q414$0.46$0.45$348.33 million$349.80 millionViewListenView Earnings Details
10/30/2014Q314$0.43$0.44$356.08 million$355.90 millionViewListenView Earnings Details
7/31/2014Q214$0.47$0.52$368.60 million$368.90 millionViewN/AView Earnings Details
5/1/2014Q114$0.41$0.38$340.90 million$346.80 millionViewListenView Earnings Details
2/20/2014Q413$0.38$0.38$348.70 million$342.70 millionViewListenView Earnings Details
10/31/2013Q3 13$0.36$0.39$333.25 million$341.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.82$0.86$349.85 million$344.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.86$0.87$344.20 million$339.40 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.56$0.61$318.75 million$321.50 millionViewListenView Earnings Details
11/1/2012Q312$0.50$0.52$306.91 million$303.80 millionViewN/AView Earnings Details
8/2/2012$0.69$0.79ViewN/AView Earnings Details
4/26/2012$0.65$0.83ViewN/AView Earnings Details
2/16/2012$0.55$0.59ViewN/AView Earnings Details
11/1/2011$0.54$0.53ViewN/AView Earnings Details
7/28/2011$0.68$0.62ViewN/AView Earnings Details
4/28/2011$0.62$0.60ViewN/AView Earnings Details
2/17/2011$0.46$0.42ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for West Pharmaceutical Services (NYSE:WST)
Current Year EPS Consensus Estimate: $2.22 EPS
Next Year EPS Consensus Estimate: $2.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.52$0.53$0.53
Q2 20161$0.56$0.56$0.56
Q3 20161$0.55$0.55$0.55
Q4 20161$0.56$0.56$0.56
Q1 20171$0.62$0.62$0.62
Q2 20171$0.67$0.67$0.67
Q3 20171$0.66$0.66$0.66
Q4 20171$0.67$0.67$0.67
(Data provided by Zacks Investment Research)


Current Dividend Information for West Pharmaceutical Services (NYSE:WST)
Annual Dividend:$0.48
Dividend Yield:0.65%
Dividend Growth:7.20% (3 Year Average)
Payout Ratio:35.04% (Based on Trailing 12 Months of Earnings)
21.62% (Based on Current Year Consensus EPS Estimate)
18.32% (Based on Next Year Consensus EPS Estimate)
Track Record:23 Years of Consecutive Dividend Growth

Dividend History for West Pharmaceutical Services (NYSE:WST)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for West Pharmaceutical Services (NYSE:WST)
Insider Ownership Percentage: 5.13%
Institutional Ownership Percentage: 90.24%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2016Karen FlynnSVPSell14,581$83.28$1,214,305.68View SEC Filing  
8/23/2016Paula A JohnsonDirectorSell3,042$81.55$248,075.10View SEC Filing  
6/2/2016Daniel MaloneVPSell3,950$74.95$296,052.50View SEC Filing  
5/25/2016Thomas W HofmannDirectorSell2,466$73.57$181,423.62View SEC Filing  
3/1/2016Michael A AndersonVPSell16,414$63.58$1,043,602.12View SEC Filing  
2/29/2016Thomas W HofmannDirectorSell3,042$62.70$190,733.40View SEC Filing  
2/25/2016Heino LennartzInsiderSell5,680$62.47$354,829.60View SEC Filing  
2/24/2016Heino LennartzInsiderSell19,658$59.45$1,168,668.10View SEC Filing  
2/23/2016Paula A. JohnsonDirectorSell7,800$59.39$463,242.00View SEC Filing  
2/22/2016Warwick BedwellInsiderSell16,042$59.52$954,819.84View SEC Filing  
11/25/2015John E. PaproskiinsiderSell17,560$63.41$1,113,479.60View SEC Filing  
11/12/2015Heino LennartzInsiderSell3,500$61.87$216,545.00View SEC Filing  
11/6/2015Michael A AndersonVPSell3,000$62.18$186,540.00View SEC Filing  
11/5/2015Michael A. AndersonVPSell10,000$61.98$619,800.00View SEC Filing  
11/4/2015Daniel MaloneVPSell4,456$61.65$274,712.40View SEC Filing  
8/17/2015William J FedericiCFOSell52,678$59.72$3,145,930.16View SEC Filing  
5/28/2015Heino LennartzInsiderSell9,584$55.00$527,120.00View SEC Filing  
5/22/2015Karen FlynnInsiderSell3,091$55.24$170,746.84View SEC Filing  
5/21/2015Eric Mark GreenCEOBuy18,300$54.89$1,004,487.00View SEC Filing  
5/18/2015Karen FlynnInsiderSell1,909$55.00$104,995.00View SEC Filing  
5/15/2015Donald E Morel JrCEOSell20,000$54.29$1,085,800.00View SEC Filing  
2/27/2015Richard D LuzziVPSell10,000$54.85$548,500.00View SEC Filing  
2/26/2015Michael A AndersonVPSell4,682$54.93$257,182.26View SEC Filing  
2/25/2015Heino LennartzInsiderSell3,617$54.82$198,283.94View SEC Filing  
2/24/2015John E PaproskiInsiderSell9,282$52.87$490,739.34View SEC Filing  
2/23/2015Heino LennartzInsiderSell21,040$53.40$1,123,536.00View SEC Filing  
2/23/2015Patrick J ZennerDirectorSell12,800$53.69$687,232.00View SEC Filing  
11/26/2014Richard D LuzziVPSell8,000$52.11$416,880.00View SEC Filing  
11/21/2014William J FedericiCFOSell3,000$51.22$153,660.00View SEC Filing  
11/20/2014Donald E Morel JrCEOSell20,000$51.30$1,026,000.00View SEC Filing  
11/13/2014John R GaileyVPSell28,000$52.37$1,466,360.00View SEC Filing  
11/11/2014Michael A AndersonVPSell4,600$51.73$237,958.00View SEC Filing  
11/10/2014Warwick BedwellInsiderSell6,306$49.95$314,984.70View SEC Filing  
8/21/2014Richard D LuzziVPSell10,000$44.07$440,700.00View SEC Filing  
8/20/2014John R GaileyVPSell20,000$43.96$879,200.00View SEC Filing  
8/19/2014Michael A AndersonVPSell9,800$43.41$425,418.00View SEC Filing  
8/18/2014William J FedericiCFOSell38,366$42.56$1,632,856.96View SEC Filing  
8/13/2014Heino LennartzInsiderSell7,555$39.65$299,555.75View SEC Filing  
8/11/2014Heino LennartzInsiderSell11,445$40.00$457,800.00View SEC Filing  
8/7/2014John E PaproskiInsiderSell14,000$40.44$566,160.00View SEC Filing  
5/30/2014Richard D LuzziVPSell22,828$42.17$962,656.76View SEC Filing  
5/29/2014Heino LennartzInsiderSell2,000$43.00$86,000.00View SEC Filing  
2/28/2014Heino LennartzInsiderSell16,044$45.84$735,456.96View SEC Filing  
2/26/2014Patrick J ZennerDirectorSell12,800$46.12$590,336.00View SEC Filing  
2/24/2014Warwick BedwellInsiderSell24,606$47.49$1,168,538.94View SEC Filing  
11/26/2013Donald E Morel JrCEOSell35,000$48.60$1,701,000.00View SEC Filing  
11/22/2013William J FedericiCFOSell36,000$48.34$1,740,240.00View SEC Filing  
11/19/2013Karen FlynnInsiderSell5,500$47.75$262,625.00View SEC Filing  
11/8/2013Michael A AndersonVPSell9,200$46.80$430,560.00View SEC Filing  
11/7/2013Heino LennartzInsiderSell5,102$46.70$238,263.40View SEC Filing  
11/6/2013Michael A AndersonVPSell6,000$46.53$279,180.00View SEC Filing  
11/5/2013John R GaileyVPSell6,000$46.83$280,980.00View SEC Filing  
11/5/2013Warwick BedwellInsiderSell6,304$46.84$295,279.36View SEC Filing  
11/4/2013Richard D LuzziVPSell38,708$46.99$1,818,888.92View SEC Filing  
8/30/2013Donald E Morel JrCEOSell10,000$74.46$744,600.00View SEC Filing  
8/27/2013John R GaileyVPSell13,749$76.77$1,055,510.73View SEC Filing  
8/22/2013L Robert JohnsonDirectorSell1,883$76.81$144,633.23View SEC Filing  
8/14/2013John E PaproskiInsiderSell6,011$79.08$475,349.88View SEC Filing  
8/12/2013Anthony WeltersDirectorSell19,200$78.43$1,505,856.00View SEC Filing  
8/8/2013Michael A AndersonVPSell4,300$78.00$335,400.00View SEC Filing  
5/31/2013Michael A AndersonVPSell4,000$68.94$275,760.00View SEC Filing  
5/28/2013Donald E Morel JrCEOSell10,000$67.87$678,700.00View SEC Filing  
5/24/2013L Robert JohnsonDirectorSell1,700$67.47$114,699.00View SEC Filing  
5/20/2013John R GaileyVPSell9,282$68.54$636,188.28View SEC Filing  
5/17/2013L Robert JohnsonDirectorSell4,000$67.80$271,200.00View SEC Filing  
5/8/2013L Robert JohnsonDirectorSell6,400$64.49$412,736.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for West Pharmaceutical Services (NYSE:WST)
prnewswire.com logoWest Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain - PR Newswire (press release) (NYSE:WST)
www.prnewswire.com - September 27 at 8:38 AM
finance.yahoo.com logoWest Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain (NYSE:WST)
finance.yahoo.com - September 26 at 8:07 PM
News IconAnalysts Take on West Pharmaceutical Services Inc. (NYSE:WST) Rating (NYSE:WST)
www.crcconnection.com - September 23 at 7:31 PM
capitalcube.com logoETF’s with exposure to West Pharmaceutical Services, Inc. : September 23, 2016 (NYSE:WST)
www.capitalcube.com - September 23 at 7:31 PM
News IconAnalysts Take the Wheel on West Pharmaceutical Services, Inc. (NYSE:WST) Shares and Where They Might Be Headed - Frisco Fastball (NYSE:WST)
friscofastball.com - September 23 at 5:45 AM
News IconAnalysts Take on West Pharmaceutical Services Inc. (NYSE:WST) Rating - Post Registrar (NYSE:WST)
postregistrar.com - September 23 at 5:45 AM
News IconWest Pharmaceutical Services(NYSE:WST) Declares Dividend of $0.1300 (NYSE:WST)
magseriesusa.net - September 22 at 7:47 PM
forbes.com logoRSI Alert: West Pharmaceutical Services (WST) Now Oversold (NYSE:WST)
www.forbes.com - September 22 at 2:15 PM
4-traders.com logoWest Pharmaceutical Services : Declares Dividend of $0.1300. (NYSE:WST)
www.4-traders.com - September 21 at 7:39 PM
finance.yahoo.com logoWest Pharm downgraded by Wells Fargo (NYSE:WST)
finance.yahoo.com - September 21 at 7:39 PM
thestreet.com logoWest Pharmaceutical (WST) Stock Stumbling, Wells Fargo Downgrades (NYSE:WST)
www.thestreet.com - September 21 at 7:39 PM
nasdaq.com logoWest Pharmaceutical Services (WST) Has Dropped To Over A 2-Month Low (NYSE:WST)
www.nasdaq.com - September 21 at 11:58 AM
News IconWest Pharmaceutical Services Inc. (WST) VP Sells $296,052.50 in ... - DailyQuint (NYSE:WST)
dailyquint.com - September 19 at 6:01 AM
investorplace.com logo5 Dividend Stocks Increasing Payouts – PM IBKC WST DHR WASH - Investorplace.com (NYSE:WST)
investorplace.com - September 16 at 7:49 PM
News IconParrent Watching: West Pharmaceutical Services Inc. Stock Faces Lower Risks Forward After Forming Wedge Up Chart ... - Chester News (NYSE:WST)
www.chesterindependent.com - September 16 at 7:49 PM
capitalcube.com logoWest Pharmaceutical Services, Inc. – Value Analysis (NYSE:WST) : September 16, 2016 (NYSE:WST)
www.capitalcube.com - September 16 at 7:49 PM
capitalcube.com logoWest Pharmaceutical Services, Inc. breached its 50 day moving average in a Bullish Manner : WST-US : September 15, 2016 (NYSE:WST)
www.capitalcube.com - September 15 at 11:56 AM
News IconStock Perspective: West Pharmaceutical Services, Inc. (NYSE:WST) Company Earnings Watch - Frisco Fastball (NYSE:WST)
friscofastball.com - September 14 at 8:22 PM
investors.com logoWest Pharmaceutical Services, Inc: WST Stock Rises on Dividend - Income Investors (NYSE:WST)
www.incomeinvestors.com - September 14 at 8:22 PM
prnewswire.com logoWest Elects New Director and Announces Increase to Quarterly Dividend - PR Newswire (press release) (NYSE:WST)
www.prnewswire.com - September 13 at 6:11 AM
News IconStock Trading Above Moving Averages: West Pharmaceutical Services, Inc. (NYSE:WST) - Post News (NYSE:WST)
www.kentuckypostnews.com - September 12 at 7:36 PM
finance.yahoo.com logo7:02 am West Pharm increases quarterly dividend to $0.13/share from $0.12/share (NYSE:WST)
finance.yahoo.com - September 12 at 7:36 PM
publicnow.com logoWest Elects New Director and Announces Increase to Quarterly Dividend (NYSE:WST)
www.publicnow.com - September 12 at 7:36 PM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclos (NYSE:WST)
biz.yahoo.com - September 12 at 7:36 PM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:WST)
biz.yahoo.com - September 7 at 12:03 PM
finance.yahoo.com logoWest to Present at Three Healthcare Conferences in September (NYSE:WST)
finance.yahoo.com - September 2 at 7:57 PM
capitalcube.com logoETF’s with exposure to West Pharmaceutical Services, Inc. : August 30, 2016 (NYSE:WST)
www.capitalcube.com - August 30 at 8:01 PM
fidaily.com logoWest Pharmaceutical Services, I (WST) Position Down in Latest Report from American Century Companies Inc Last ... - Finance Daily (NYSE:WST)
www.fidaily.com - August 16 at 8:24 PM
capitalcube.com logoETF’s with exposure to West Pharmaceutical Services, Inc. : August 16, 2016 (NYSE:WST)
www.capitalcube.com - August 16 at 8:24 PM
capitalcube.com logoWest Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NYSE:WST)
www.capitalcube.com - August 9 at 11:49 AM
finance.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Financials (NYSE:WST)
finance.yahoo.com - August 6 at 8:11 PM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 10-Q, Quarterly Report (NYSE:WST)
biz.yahoo.com - August 1 at 8:03 PM
investornewswire.com logoCan Shares Of West Pharmaceutical Services, Inc. (NYSE:WST) Hit $90? - Investor Newswire (NYSE:WST)
www.investornewswire.com - July 29 at 8:37 PM
finance.yahoo.com logoEdited Transcript of WST earnings conference call or presentation 28-Jul-16 1:00pm GMT (NYSE:WST)
finance.yahoo.com - July 29 at 4:53 PM
News IconWest Announces Second Quarter 2016 Results (NYSE:WST)
www.kswo.com - July 29 at 11:24 AM
twst.com logoWest Pharmaceutical Services Inc.: West Announces Second Quarter 2016 Results - The Wall Street Transcript (NYSE:WST)
www.twst.com - July 28 at 8:48 PM
biz.yahoo.com logoWest Pharmaceutical Services Inc Earnings Call (Q2 2016) (NYSE:WST)
biz.yahoo.com - July 28 at 11:42 AM
biz.yahoo.com logoWest Pharmaceutical Services Inc Earnings Call scheduled for 9:00 am ET today (NYSE:WST)
biz.yahoo.com - July 28 at 9:00 AM
biz.yahoo.com logoWEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Dis (NYSE:WST)
biz.yahoo.com - July 28 at 8:55 AM
sg.finance.yahoo.com logoWest Pharmaceutical tops Street 2Q forecasts (NYSE:WST)
sg.finance.yahoo.com - July 28 at 8:10 AM
4-traders.com logoWest Pharmaceutical Services : Gw&k Investment Management Lowers stake in West Pharmaceutical Services (NYSE:WST)
www.4-traders.com - July 24 at 7:46 PM
fidaily.com logoHermes Investment Management Ltd Bought A Little More West Pharmaceutical Services, I (WST) Stock (NYSE:WST)
www.fidaily.com - July 22 at 8:05 PM
fidaily.com logoEagle Asset Management Inc Sells A Little More West Pharmaceutical Services, I (WST) Stock In The Last Quarter - Finance Daily (NYSE:WST)
www.fidaily.com - July 19 at 8:31 PM
News IconStock Positive on the Year: West Pharmaceutical Services, Inc. (NYSE:WST) - TGP (NYSE:WST)
telanaganapress.com - July 19 at 8:31 PM
4-traders.com logoWEST PHARMACEUTICAL SERVICES INC. : ex-dividend day (NYSE:WST)
www.4-traders.com - July 19 at 9:16 AM
News IconKalmar Investments INC Decreased Stake in West Pharmaceuticals Services (NYSE:WST) by $33.66 Million as Shares ... - Consumer Eagle (NYSE:WST)
www.consumereagle.com - July 17 at 7:42 PM
News IconShare Performance Summary for: West Pharmaceutical Services, Inc. (NYSE:WST) - Press Telegraph (NYSE:WST)
presstelegraph.com - July 17 at 6:13 AM
News IconStock in Positive Territory for the Quarter: West Pharmaceutical Services, Inc. (NYSE:WST) - Engelwood Daily (NYSE:WST)
www.engelwooddaily.com - July 16 at 11:30 AM
nasdaq.com logoWest Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for July 18, 2016 - Nasdaq (NYSE:WST)
www.nasdaq.com - July 16 at 11:30 AM
investornewswire.com logoStrong Sell Calls For West Pharmaceutical Services, Inc. (NYSE:WST) At 0 - Investor Newswire (NYSE:WST)
www.investornewswire.com - July 16 at 11:30 AM


West Pharmaceutical Services (NYSE:WST) Chart for Wednesday, September, 28, 2016

Last Updated on 9/28/2016 by MarketBeat.com Staff